Amine Toubal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amine Toubal has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Agnès Lehuen
Université Paris Cité, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France (A.L.).
7 shared publications Lucie Beaudoin
Institut Cochin, INSERM UMR-S1016, CNRS UMR-S8104, Université Paris Cité, Paris, France
4 shared publicationsLucie Cagninacci
Institut Cochin, INSERM UMR-S1016, CNRS UMR-S8104, Université Paris Cité, Paris, France
4 shared publications- Léo Bertrand
Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris, France
3 shared publications - Nicolas Venteclef
INEM Institut Necker-Enfants Malades, INSERM U1151, CNRS UMR 8253, Université Paris Cité, Paris, France
3 shared publications Blandine Fruchet
Institut Cochin, INSERM UMR-S1016, CNRS UMR-S8104, Université Paris Cité, Paris, France
2 shared publications
Latest Publications
- 31 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Décodage du role de GPS2 dans le controle transcriptionnel de l'inflammation du tissu adipeux dans l'obésité
L'obésité est aujourd’hui considérée comme une maladie inflammatoire chronique dite de « bas grade » principalement caractérisée par une augmentation de l’inflammation du tissu adipeux. Les adipocytes et les macrophages sont connus pour jouer un rôle clé dans l’établissement, la progression et le maintien de l'inflammation. Dans mon projet de thèse, nous nous sommes particulièrement intéressés aux mécanismes transcriptionnels impliqués dans l'inflammation chronique en décodant l'action du corégulateur transcriptionnel GPS2 (G protein pathway suppressor 2) dans les adipocytes et les macrophages du tissu adipeux. Dans un premiers temps, nous avons étudié la régulation et les actions de GPS2 (et ses partenaires SMRT et NCOR) dans le tissu adipeux humains de sujets obèses par rapport à des sujets minces. Dans cette première étude, nous avons identifié un mécanisme épigénomique qui participe à la régulation de la transcription des gènes inflammatoires dans les adipocytes lors de l’obésité. Nous avons démontré que la dérégulation de GPS2 contribuait à l'inflammation du tissu adipeux en permettant à la dérépression de certains gènes inflammatoires dont l’interleukine 6. Dans la deuxième étude, nous avons caractérisé les conséquences de l’invalidation de GPS2 dans le phénotype inflammatoire des macrophages ainsi que les conséquences in vivo sur la progression de l’insulino-résistance. Pour ceci, nous avons généré un modèle de souris où GPS2 a été spécifiquement invalidé dans les macrophages (GPS2-MacKO). De manière intéressante, les souris GPS2-MacKO, présentent une expression accrue des gènes impliqués dans la voie de signalisation des TLR et des chimiokines dans les macrophages isolés. Par conséquent, une augmentation significative de l'infiltration des macrophages dans le tissu adipeux est observée dans un contexte d’obésité induisant une altération de l’homéostasie glucidique. Par nos approches génomiques, transcriptomiques et épigénomiques, nous avons pu révéler les voies de signalisations spécifiquement contrôlées par GPS2. Ces travaux démontrent également l’importance des régulations épigénomiques dans l'inflammation métabolique du tissu adipeux durant l'obésité.
- 31 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Décodage du role de GPS2 dans le controle transcriptionnel de l'inflammation du tissu adipeux dans l'obésité
L'obésité est aujourd’hui considérée comme une maladie inflammatoire chronique dite de « bas grade » principalement caractérisée par une augmentation de l’inflammation du tissu adipeux. Les adipocytes et les macrophages sont connus pour jouer un rôle clé dans l’établissement, la progression et le maintien de l'inflammation. Dans mon projet de thèse, nous nous sommes particulièrement intéressés aux mécanismes transcriptionnels impliqués dans l'inflammation chronique en décodant l'action du corégulateur transcriptionnel GPS2 (G protein pathway suppressor 2) dans les adipocytes et les macrophages du tissu adipeux. Dans un premiers temps, nous avons étudié la régulation et les actions de GPS2 (et ses partenaires SMRT et NCOR) dans le tissu adipeux humains de sujets obèses par rapport à des sujets minces. Dans cette première étude, nous avons identifié un mécanisme épigénomique qui participe à la régulation de la transcription des gènes inflammatoires dans les adipocytes lors de l’obésité. Nous avons démontré que la dérégulation de GPS2 contribuait à l'inflammation du tissu adipeux en permettant à la dérépression de certains gènes inflammatoires dont l’interleukine 6. Dans la deuxième étude, nous avons caractérisé les conséquences de l’invalidation de GPS2 dans le phénotype inflammatoire des macrophages ainsi que les conséquences in vivo sur la progression de l’insulino-résistance. Pour ceci, nous avons généré un modèle de souris où GPS2 a été spécifiquement invalidé dans les macrophages (GPS2-MacKO). De manière intéressante, les souris GPS2-MacKO, présentent une expression accrue des gènes impliqués dans la voie de signalisation des TLR et des chimiokines dans les macrophages isolés. Par conséquent, une augmentation significative de l'infiltration des macrophages dans le tissu adipeux est observée dans un contexte d’obésité induisant une altération de l’homéostasie glucidique. Par nos approches génomiques, transcriptomiques et épigénomiques, nous avons pu révéler les voies de signalisations spécifiquement contrôlées par GPS2. Ces travaux démontrent également l’importance des régulations épigénomiques dans l'inflammation métabolique du tissu adipeux durant l'obésité.
- Open Access
- 20 September 2025
- Published by Elsevier in Metabolism
- Vol. 174, 156396
BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
- 20 September 2025
- Published by Elsevier in Metabolism
- Vol. 174, 156396
Open AccessBMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
- Open Access
BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
Contemporary lifestyle modifications such as changes in nutritional and sleep/wake rhythms increase the risk of metabolic and inflammatory complications linked to obesity, including type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH). BMAL2 (Brain and Muscle ARNT Like Protein 2) is a transcription factor belonging to the circadian clock transcriptional feedback loop which synchronizes internal biological rhythms to environment. In humans, reduced expression in white adipose tissue (WAT) and specific polymorphisms of BMAL2 are associated with obesity and T2D. In this study we report that Bmal2 invalidation in mice leads to increased body weight gain during diet-induced obesity. Loss of BMAL2 triggers the inflammatory response by increasing Tnfα expression and modifying adipocyte progenitor fate. This results in reduced lipid storage capacity within the WAT and increased ectopic storage in the liver. These functional and structural alterations culminate in the onset of hepatic steatosis and insulin resistance in liver and WAT. Overall, our investigations underscore the role of BMAL2 in the development and function of adipocytes, as well as in their inflammatory potential within the WAT. Our findings contribute to the understanding of the role of circadian clock genes in obesity and interconnected metabolic complications. Highlights: The transcription factor BMAL2 is involved in metabolic complications of obesity in a mouse model of diet-induced obesity Invalidation of Bmal2 worsens insulin resistance and hepatic steatosis induced by high fat diet Invalidation of Bmal2 impairs visceral adipose tissue adaptation capacity in promoting inflammation and adipose progenitor decline Graphical
Open AccessBMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
Contemporary lifestyle modifications such as changes in nutritional and sleep/wake rhythms increase the risk of metabolic and inflammatory complications linked to obesity, including type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH). BMAL2 (Brain and Muscle ARNT Like Protein 2) is a transcription factor belonging to the circadian clock transcriptional feedback loop which synchronizes internal biological rhythms to environment. In humans, reduced expression in white adipose tissue (WAT) and specific polymorphisms of BMAL2 are associated with obesity and T2D. In this study we report that Bmal2 invalidation in mice leads to increased body weight gain during diet-induced obesity. Loss of BMAL2 triggers the inflammatory response by increasing Tnfα expression and modifying adipocyte progenitor fate. This results in reduced lipid storage capacity within the WAT and increased ectopic storage in the liver. These functional and structural alterations culminate in the onset of hepatic steatosis and insulin resistance in liver and WAT. Overall, our investigations underscore the role of BMAL2 in the development and function of adipocytes, as well as in their inflammatory potential within the WAT. Our findings contribute to the understanding of the role of circadian clock genes in obesity and interconnected metabolic complications. Highlights: The transcription factor BMAL2 is involved in metabolic complications of obesity in a mouse model of diet-induced obesity Invalidation of Bmal2 worsens insulin resistance and hepatic steatosis induced by high fat diet Invalidation of Bmal2 impairs visceral adipose tissue adaptation capacity in promoting inflammation and adipose progenitor decline Graphical
- 1 July 2021
- Published by Elsevier in Mucosal Immunology
- Vol. 14 (4) , 803-814
MAIT cells, guardians of skin and mucosa?
- 1 July 2021
- Published by Elsevier in Mucosal Immunology
- Vol. 14 (4) , 803-814
MAIT cells, guardians of skin and mucosa?
- 26 May 2021
- Published by Springer Nature in Nature Immunology
- Vol. 22 (6) , 681-682
Macrophages make the bed for early iNKT cells
- 26 May 2021
- Published by Springer Nature in Nature Immunology
- Vol. 22 (6) , 681-682
Macrophages make the bed for early iNKT cells
- Open Access
- 2 February 2021
- Published by Springer Nature in Nature Immunology
- Vol. 22 (3) , 322-335
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
Immune system dysfunction is paramount in coronavirus disease 2019 (COVID-19) severity and fatality rate. Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in mucosal immunity and protection against viral infections. Here, we studied the immune cell landscape, with emphasis on MAIT cells, in cohorts totaling 208 patients with various stages of disease. MAIT cell frequency is strongly reduced in blood. They display a strong activated and cytotoxic phenotype that is more pronounced in lungs. Blood MAIT cell alterations positively correlate with the activation of other innate cells, proinflammatory cytokines, notably interleukin (IL)-18, and with the severity and mortality of severe acute respiratory syndrome coronavirus 2 infection. We also identified a monocyte/macrophage interferon (IFN)-α–IL-18 cytokine shift and the ability of infected macrophages to induce the cytotoxicity of MAIT cells in an MR1-dependent manner. Together, our results suggest that altered MAIT cell functions due to IFN-α–IL-18 imbalance contribute to disease severity, and their therapeutic manipulation may prevent deleterious inflammation in COVID-19 aggravation.
- 2 February 2021
- Published by Springer Nature in Nature Immunology
- Vol. 22 (3) , 322-335
Open AccessOutcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
Immune system dysfunction is paramount in coronavirus disease 2019 (COVID-19) severity and fatality rate. Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in mucosal immunity and protection against viral infections. Here, we studied the immune cell landscape, with emphasis on MAIT cells, in cohorts totaling 208 patients with various stages of disease. MAIT cell frequency is strongly reduced in blood. They display a strong activated and cytotoxic phenotype that is more pronounced in lungs. Blood MAIT cell alterations positively correlate with the activation of other innate cells, proinflammatory cytokines, notably interleukin (IL)-18, and with the severity and mortality of severe acute respiratory syndrome coronavirus 2 infection. We also identified a monocyte/macrophage interferon (IFN)-α–IL-18 cytokine shift and the ability of infected macrophages to induce the cytotoxicity of MAIT cells in an MR1-dependent manner. Together, our results suggest that altered MAIT cell functions due to IFN-α–IL-18 imbalance contribute to disease severity, and their therapeutic manipulation may prevent deleterious inflammation in COVID-19 aggravation.
- 1 February 2021
- Published by Elsevier in Molecular Immunology
- Vol. 130, 142-147
Role of MAIT cells in metabolic diseases
- 1 February 2021
- Published by Elsevier in Molecular Immunology
- Vol. 130, 142-147
Role of MAIT cells in metabolic diseases
- Open Access
- 24 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-20
Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity
Obesity is associated with low-grade chronic inflammation promoting insulin-resistance and diabetes. Gut microbiota dysbiosis is a consequence as well as a driver of obesity and diabetes. Mucosal-associated invariant T cells (MAIT) are innate-like T cells expressing a semi-invariant T cell receptor restricted to the non-classical MHC class I molecule MR1 presenting bacterial ligands. Here we show that during obesity MAIT cells promote inflammation in both adipose tissue and ileum, leading to insulin resistance and impaired glucose and lipid metabolism. MAIT cells act in adipose tissue by inducing M1 macrophage polarization in an MR1-dependent manner and in the gut by inducing microbiota dysbiosis and loss of gut integrity. Both MAIT cell-induced tissue alterations contribute to metabolic dysfunction. Treatment with MAIT cell inhibitory ligand demonstrates its potential as a strategy against inflammation, dysbiosis and metabolic disorders.
- 24 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-20
Open AccessMucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity
Obesity is associated with low-grade chronic inflammation promoting insulin-resistance and diabetes. Gut microbiota dysbiosis is a consequence as well as a driver of obesity and diabetes. Mucosal-associated invariant T cells (MAIT) are innate-like T cells expressing a semi-invariant T cell receptor restricted to the non-classical MHC class I molecule MR1 presenting bacterial ligands. Here we show that during obesity MAIT cells promote inflammation in both adipose tissue and ileum, leading to insulin resistance and impaired glucose and lipid metabolism. MAIT cells act in adipose tissue by inducing M1 macrophage polarization in an MR1-dependent manner and in the gut by inducing microbiota dysbiosis and loss of gut integrity. Both MAIT cell-induced tissue alterations contribute to metabolic dysfunction. Treatment with MAIT cell inhibitory ligand demonstrates its potential as a strategy against inflammation, dysbiosis and metabolic disorders.
- Open Access
- 6 June 2016
- Published by Springer Nature in Nature Medicine
- Vol. 22 (7) , 780-791
Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes
The co-repressor GPS2 acts in macrophages to regulate their activation in obesity-induced inflammation, and appropriate GPS2 function is required to maintain insulin sensitivity in mice and humans with obesity.
- 6 June 2016
- Published by Springer Nature in Nature Medicine
- Vol. 22 (7) , 780-791
Open AccessLoss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes
The co-repressor GPS2 acts in macrophages to regulate their activation in obesity-induced inflammation, and appropriate GPS2 function is required to maintain insulin sensitivity in mice and humans with obesity.
- 1 May 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (5) , 1008-1010
Lights on MAIT cells, a new immune player in liver diseases
- 1 May 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (5) , 1008-1010
Lights on MAIT cells, a new immune player in liver diseases